Target intelligence / Profile preview

Lachesis muta C-type lectin-like hemostasis-modifying toxins (Lm-Snaclecs)

Target
Lm-Snaclecs
Molecular classification
C-type lectin-like protein, Snaclec, Snake venom toxin
01

Overview

Lachesis muta C-type lectin-like hemostasis-modifying toxins, commonly known as Snaclecs, are a significant class of non-enzymatic proteins found in the venom of the South American bushmaster snake (Lachesis muta) (Siigur et al., 2010). These toxins function by binding with high specificity to various components of the human hemostatic system, including platelet receptors like glycoprotein Ib (GPIb) and glycoprotein VI (GPVI), as well as blood coagulation factors (Siigur et al., 2010; MDPI, 2012). This binding can lead to either the activation or inhibition of platelet aggregation and the disruption of the coagulation cascade, resulting in severe clinical symptoms such as systemic hemorrhage, coagulopathy, and hypotension (NIH, 2019). Some specific members, such as Mutacytin-1, have also demonstrated cardiotoxic properties, inducing heart rate alterations and thrombus formation in experimental models (Perdomo et al., 2019). In medical practice, these toxins are the primary targets for neutralization by specific or polyvalent antivenoms, which prevent the toxins from interacting with their physiological targets (NIH, 2019). Furthermore, due to their potent and selective interactions with the vascular system, they are extensively studied as lead structures for the development of new anticoagulant and antithrombotic therapeutic agents (Siigur et al., 2010).

Other names
SnaclecsC-type lectin-like proteinsCTLPsMutinaMutacytin-1Bushmaster lectinLm-CLPSnake venom C-type lectins
02

Mechanism of action

Antivenom antibodies bind to and neutralize the toxins, preventing their interaction with platelet receptors and coagulation factors. Simple sugars like galactose and lactose can competitively inhibit the carbohydrate-binding activity of certain members of this toxin class in vitro.

03

Biological functions

Platelet aggregation modulationHemagglutinationCoagulation factor bindingCardiotoxicityHypotension induction
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageThrombosis
05

Safety considerations

Severe systemic hemorrhageCardiovascular collapseAnaphylaxis (to antivenom)Acute kidney injuryTissue necrosis
06

Interacting drugs

Lachesis-specific antivenom

3 more in the full profile.

07

Biomarkers

Platelet countProthrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelsD-dimer

Beyond the preview

Go deeper on Lachesis muta C-type lectin-like hemostasis-modifying toxins (Lm-Snaclecs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lachesis muta C-type lectin-like hemostasis-modifying toxins (Lm-Snaclecs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call